December 2015—NeoGenomics has reached an agreement to acquire Clarient and its wholly owned subsidiary Clarient Diagnostic Services. Clarient, a unit of GE Healthcare’s Life Sciences business, is based in Houston and in Aliso Viejo, Calif., and has approximately 415 employees. Clarient had 2014 revenue of $127 million.
Read More »Home >> Tag Archives: Clarient Diagnostics
PD-L1 companion diagnostic for Merck’s Keytruda, 11/15
November 2015—Clarient Diagnostics will offer the FDA-approved PD-L1 companion diagnostic, which will help identify patients most likely to benefit from Merck’s lung cancer drug Keytruda.
Read More »Clarient modifies SeqWright, 3/14
March 2014—Clarient Diagnostic Services, a GE Healthcare company, has modified its facility in Houston to support a full range of clinical diagnostic testing for cancer. The facility, which operates under the name SeqWright Genomic Services, is a CLIA-certified lab offering nucleic acid sequencing and genomics services.
Read More »